Literature DB >> 22326959

Cxcr2 and Cxcl5 regulate the IL-17/G-CSF axis and neutrophil homeostasis in mice.

Junjie Mei1, Yuhong Liu, Ning Dai, Christian Hoffmann, Kristin M Hudock, Peggy Zhang, Susan H Guttentag, Jay K Kolls, Paula M Oliver, Frederic D Bushman, G Scott Worthen.   

Abstract

Neutrophils are essential for maintaining innate immune surveillance under normal conditions, but also represent a major contributor to tissue damage during inflammation. Neutrophil homeostasis is therefore tightly regulated. Cxcr2 plays a critical role in neutrophil homeostasis, as Cxcr2(-/-) mice demonstrate mild neutrophilia and severe neutrophil hyperplasia in the bone marrow. The mechanisms underlying these phenotypes, however, are unclear. We report here that Cxcr2 on murine neutrophils inhibits the IL-17A/G-CSF axis that regulates neutrophil homeostasis. Furthermore, enterocyte-derived Cxcl5 in the gut regulates IL-17/G-CSF levels and contributes to Cxcr2-dependent neutrophil homeostasis. Conversely, G-CSF was required for Cxcl5-dependent regulation of neutrophil homeostasis, and inhibition of IL-17A reduced plasma G-CSF concentrations and marrow neutrophil numbers in both Cxcl5(-/-) and Cxcr2(-/-) mice. Cxcr2(-/-) mice constitutively expressed IL-17A and showed increased numbers of IL-17A-producing cells in the lung, terminal ileum, and spleen. Most IL-17-producing splenocytes were responsive to IL-1β plus IL-23 in vitro. Depletion of commensal microbes by antibiotic treatment in Cxcr2(-/-) mice markedly decreased IL-17A and G-CSF expression, neutrophilia, and marrow myeloid hyperplasia. These data suggest a critical role for Cxcr2, Cxcl5, and commensal bacteria in regulation of the IL-17/G-CSF axis and neutrophil homeostasis at mucosal sites and have implications for the development of treatments for pathologies resulting from either excessive or ineffective neutrophil responses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22326959      PMCID: PMC3287232          DOI: 10.1172/JCI60588

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis.

Authors:  Seth Rakoff-Nahoum; Justin Paglino; Fatima Eslami-Varzaneh; Stephen Edberg; Ruslan Medzhitov
Journal:  Cell       Date:  2004-07-23       Impact factor: 41.582

2.  Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis.

Authors:  Benjamin T Suratt; Joseph M Petty; Scott K Young; Kenneth C Malcolm; Jonathan G Lieber; Jerry A Nick; Jose-Angel Gonzalo; Peter M Henson; G Scott Worthen
Journal:  Blood       Date:  2004-03-30       Impact factor: 22.113

3.  CXCL5 regulates chemokine scavenging and pulmonary host defense to bacterial infection.

Authors:  Junjie Mei; Yuhong Liu; Ning Dai; Michael Favara; Teshell Greene; Samithamby Jeyaseelan; Mortimer Poncz; Janet S Lee; G Scott Worthen
Journal:  Immunity       Date:  2010-07-23       Impact factor: 31.745

4.  CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia.

Authors:  W C Tsai; R M Strieter; B Mehrad; M W Newstead; X Zeng; T J Standiford
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

5.  Chemokine-dependent neutrophil recruitment in a murine model of Legionella pneumonia: potential role of neutrophils as immunoregulatory cells.

Authors:  K Tateda; T A Moore; M W Newstead; W C Tsai; X Zeng; J C Deng; G Chen; R Reddy; K Yamaguchi; T J Standiford
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

6.  G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood.

Authors:  Craig L Semerad; Fulu Liu; Alyssa D Gregory; Katherine Stumpf; Daniel C Link
Journal:  Immunity       Date:  2002-10       Impact factor: 31.745

7.  G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells.

Authors:  Hyun Kyung Kim; Maria De La Luz Sierra; Cassin Kimmel Williams; A Virginia Gulino; Giovanna Tosato
Journal:  Blood       Date:  2006-03-14       Impact factor: 22.113

8.  Pivotal role of granulocyte colony-stimulating factor in the development of progenitors in the common myeloid pathway.

Authors:  Michael K Richards; Fulu Liu; Hiromi Iwasaki; Koichi Akashi; Daniel C Link
Journal:  Blood       Date:  2003-07-31       Impact factor: 22.113

9.  The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo.

Authors:  B I Lord; M H Bronchud; S Owens; J Chang; A Howell; L Souza; T M Dexter
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

10.  G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.

Authors:  Isabelle Petit; Martine Szyper-Kravitz; Arnon Nagler; Meir Lahav; Amnon Peled; Liliana Habler; Tanya Ponomaryov; Russell S Taichman; Fernando Arenzana-Seisdedos; Nobutaka Fujii; Judith Sandbank; Dov Zipori; Tsvee Lapidot
Journal:  Nat Immunol       Date:  2002-06-17       Impact factor: 25.606

View more
  94 in total

1.  Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model.

Authors:  J Yan; C Tingey; R Lyde; T C Gorham; D K Choo; A Muthumani; D Myles; L P Weiner; K A Kraynyak; E L Reuschel; T H Finkel; J J Kim; N Y Sardesai; K E Ugen; K Muthumani; D B Weiner
Journal:  Cancer Gene Ther       Date:  2014-11-14       Impact factor: 5.987

2.  Balancing the books.

Authors:  Olive Leavy
Journal:  Nat Rev Immunol       Date:  2012-02-24       Impact factor: 53.106

3.  Delayed resolution of lung inflammation in Il-1rn-/- mice reflects elevated IL-17A/granulocyte colony-stimulating factor expression.

Authors:  Kristin M Hudock; Yuhong Liu; Junjie Mei; Roberta C Marino; Jason E Hale; Ning Dai; G Scott Worthen
Journal:  Am J Respir Cell Mol Biol       Date:  2012-05-16       Impact factor: 6.914

Review 4.  The mercurial nature of neutrophils: still an enigma in ARDS?

Authors:  Andrew E Williams; Rachel C Chambers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-12-06       Impact factor: 5.464

5.  Commensal bacteria-dependent select expression of CXCL2 contributes to periodontal tissue homeostasis.

Authors:  Camille Zenobia; Xiao Long Luo; Ahmed Hashim; Toshiharu Abe; Lijian Jin; Yucheng Chang; Zhi Chao Jin; Jian Xun Sun; George Hajishengallis; Mike A Curtis; Richard P Darveau
Journal:  Cell Microbiol       Date:  2013-03-22       Impact factor: 3.715

Review 6.  Heterogeneity across the murine small and large intestine.

Authors:  Rowann Bowcutt; Ruth Forman; Maria Glymenaki; Simon Richard Carding; Kathryn Jane Else; Sheena Margaret Cruickshank
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

7.  Treg-Cell Control of a CXCL5-IL-17 Inflammatory Axis Promotes Hair-Follicle-Stem-Cell Differentiation During Skin-Barrier Repair.

Authors:  Anubhav N Mathur; Bahar Zirak; Ian C Boothby; Madge Tan; Jarish N Cohen; Thea M Mauro; Pooja Mehta; Margaret M Lowe; Abul K Abbas; Niwa Ali; Michael D Rosenblum
Journal:  Immunity       Date:  2019-03-19       Impact factor: 31.745

8.  Vitamin D-binding protein deficiency in mice decreases systemic and select tissue levels of inflammatory cytokines in a murine model of acute muscle injury.

Authors:  Richard R Kew; Tahmineh Tabrizian; James A Vosswinkel; James E Davis; Randeep S Jawa
Journal:  J Trauma Acute Care Surg       Date:  2018-06       Impact factor: 3.313

9.  Platelet-Specific Chemokines Contribute to the Pathogenesis of Acute Lung Injury.

Authors:  Khalil Bdeir; Kandace Gollomp; Marta Stasiak; Junjie Mei; Izabela Papiewska-Pajak; Guohua Zhao; G Scott Worthen; Douglas B Cines; Mortimer Poncz; M Anna Kowalska
Journal:  Am J Respir Cell Mol Biol       Date:  2017-02       Impact factor: 6.914

Review 10.  CXCR2: a target for pancreatic cancer treatment?

Authors:  Kathleen M Hertzer; Graham W Donald; O Joe Hines
Journal:  Expert Opin Ther Targets       Date:  2013-02-21       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.